Rare Metals Metals and Alloys

Engineered Hf <sub>0.7</sub> Ti <sub>0.3</sub> O <sub>2</sub> nanoparticles for efficient radiotherapy on rectal cancer via synergistically enhanced radiation deposition and ROS production

Juan Du, Yong‐Long Ye, Chao‐Xiang Xie, Jia‐Yong Luo, Kai‐Wei Xu, Ya‐Bing Sun, Liang‐Xue Lai, Wen‐Zhi Ren, Jun‐Ming Guo, Ai‐Guo Wu, Kai‐Tai Liu
Springer Nature · 2025-09-23 · DOI 10.1007/s12598-025-03595-2

Abstract

Abstract Preoperative radiotherapy is a cornerstone of treatment for locally advanced rectal cancer, but intrinsic tumor cell radio resistance remains a primary obstacle limiting therapeutic efficacy. Herein, for the first time, we successfully constructed Hf 0.7 Ti 0.3 O 2 @PEG (HT) nanoparticles by introducing titanium (Ti) into hafnium dioxide (HfO 2 ). These HT nanoparticles synergistically combined the superior X‐ray energy deposition capability of Hf and the efficient radiation‐induced ROS generation performance of Ti, leading to a 1.4‐fold higher ROS yield compared to HfO 2 . Moreover, HT nanoparticles significantly enhanced radiosensitivity by inducing extensive DNA damage and oxidative stress in tumor cells. This resulted in a tumor inhibition rate of 87.7% ± 2.1% in mouse models. Notably, HT nanoparticles enabled a marked reduction in radiation dose while maintaining therapeutic efficacy and safety, overcoming the major limitation of conventional HfO 2 nanoradiosensitizers in ROS generation. This study presents a promising new approach for rectal cancer radiotherapy and holds significant potential for improving outcomes in radioresistant rectal cancer.

Read at publisher →